Physician

James Kevin Royal, DR.

According to 2025 Medicare claims, James Royal, DR. (NPI: 1790872174) practices internal medicine in the Auburn-Opelika, AL market, with the plurality of this provider's patient population coming from Lee, AL. This provider's primary affiliated billing organization is INTERNAL MEDICINE ASSOCIATES P.C. (NPI: 1225108715; TIN: 630809798) and primary practice location at 36801-5449. Royal is affiliated with the Aledade 79 AL MSSP Enhanced (ACO ID: A4894), participating under the MSSP model.

Royal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 466 traditional Medicare patients, billed 4,977 HCPCS/CPT codes, and received $151,019 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 20,686 prescription claims across 1,292 beneficiaries totaling $1,800,404 in drug costs, led by Ozempic (Semaglutide). DME data shows 250 claims. Open Payments data shows 54 records totaling $950. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $871,575 to $1,800,404. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $73,431 and ending at $45,502.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	775	11,654	$193,617
2016	824	12,024	$199,831
2017	629	8,702	$144,515
2018	704	7,912	$162,003
2019	689	6,380	$178,548
2020	683	6,066	$175,265
2021	615	4,508	$198,501
2022	555	4,901	$187,898
2023	534	6,401	$191,688
2024	466	4,977	$151,019

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	706	14,820	$871,575
2016	737	15,289	$905,594
2017	796	15,263	$921,564
2018	924	15,442	$1,034,671
2019	1,002	16,865	$1,245,353
2020	1,024	19,040	$1,402,758
2021	1,054	19,651	$1,530,733
2022	1,061	19,213	$1,658,448
2023	1,079	20,564	$1,931,391
2024	1,292	20,686	$1,800,404

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	211	1,049	$65,300
2016	173	925	$37,001
2017	100	628	$23,127
2018	78	507	$10,795
2019	77	405	$20,834
2020	51	526	$38,602
2021	53	406	$38,793
2022	45	329	$35,149
2023	51	301	$45,741
2024	37	250	$45,312

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	301	301	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	428	1,052	$73
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	54	71	$58
71046	X-ray of chest, 2 views	58	71	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	360	620	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	310	9,584	$311,482
Jardiance	Empagliflozin	149	8,255	$158,011
Eliquis	Apixaban	214	6,996	$135,147
Mounjaro	Tirzepatide	96	3,370	$125,755
Trulicity	Dulaglutide	112	3,408	$109,576

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	17	67	$33,420
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	19	$6,327
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	23	$2,629
E1392	Portable oxygen concentrator, rental	Y	N/R	19	$854
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	15	$668

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	54	$950	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Kevin Royal, DR.?

Tedicare shows public-source Medicare data for James Kevin Royal, DR. (NPI 1790872174), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Kevin Royal, DR. have ACO affiliation data?

James Kevin Royal, DR. is shown with ACO affiliation data for Aledade 79 AL MSSP Enhanced (MSSP, ACO ID A4894).

What billing organization is linked to James Kevin Royal, DR.?

James Kevin Royal, DR. is linked to INTERNAL MEDICINE ASSOCIATES P.C. (billing NPI 1225108715) in the available physician profile data.

Does James Kevin Royal, DR. have Open Payments data?

James Kevin Royal, DR. has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.